Literature DB >> 24905888

Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia.

Hiroko Yamada1, Mayumi Fujimoto, Somana Svay, Olline Lim, Sirany Hok, Noboru Goto, Masayuki Ohisa, Tomoyuki Akita, Junko Matsuo, Son Huy Do, Keiko Katayama, Yuzo Miyakawa, Junko Tanaka.   

Abstract

AIM: We investigated hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among adults in Siem Reap, Cambodia, to consider the prevention strategy in cooperation with the Ministry of Health in Cambodia.
METHODS: Serological tests for determining HBV and HCV infections and questionnaires were performed from 2010 to 2012 among the general population in the province of Siem Reap. Multivariate logistic regression analysis was conducted to clarify the factors related to HBV and HCV infections.
RESULTS: There were 483 participants, comprising 194 men and 289 women (age range, 18-89 years). The prevalence of hepatitis B surface antigen was not very high at 4.6%, while anti-hepatitis B core (anti-HBc) was high at 38.5%. All HBV DNA samples were classified as genotype C. Anti-HBc showed the trend that the older the age, the higher the positive rate (P = 0.0002). The prevalence of HCV RNA and anti-HCV were 2.3% and 5.8%, respectively. HCV RNA was detected in 39.3% of anti-HCV positive samples and most of them were classified as genotype 6 (54.5%) and 1 (27.3%). Remarkably, in multivariate logistic regression analysis, history of operation and blood transfusion were significantly associated with the positivity for HBV infection and HCV RNA, respectively.
CONCLUSION: Our results showed that operation and blood transfusion were potential risk factors for HBV and HCV infection, respectively, and supposed that horizontal HBV transmission may be frequent in adults in Cambodia. Hence, for reducing HBV and HCV infections, it is necessary to improve the safety of blood and medical treatment.
© 2014 The Japan Society of Hepatology.

Entities:  

Keywords:  Cambodia; adults; hepatitis B virus; hepatitis C virus; seroepidemiology

Year:  2014        PMID: 24905888     DOI: 10.1111/hepr.12367

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  18 in total

1.  Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey.

Authors:  Adebola T Olayinka; Akin Oyemakinde; Muhammad S Balogun; Anthonia Ajudua; Patrick Nguku; Moses Aderinola; Abiodun Egwuenu-Oladejo; Simeon W Ajisegiri; Samuel Sha'aibu; Bolanle O P Musa; Saheed Gidado; Abdulsalami Nasidi
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

Review 2.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission.

Authors:  Mohamed A Daw; Abdallah El-Bouzedi; Aghnaya A Dau
Journal:  BMC Res Notes       Date:  2015-08-21

4.  Hepatitis E Virus in Cambodia: Prevalence among the General Population and Complete Genome Sequence of Genotype 4.

Authors:  Hiroko Yamada; Kazuaki Takahashi; Olline Lim; Somana Svay; Channarena Chuon; Sirany Hok; Son Huy Do; Mayumi Fujimoto; Tomoyuki Akita; Noboru Goto; Keiko Katayama; Masahiro Arai; Junko Tanaka
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

5.  Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia.

Authors:  Rujipat Wasitthankasem; Sompong Vongpunsawad; Nipaporn Siripon; Chutima Suya; Phrutsada Chulothok; Kasemporn Chaiear; Pairaya Rujirojindakul; Sawan Kanjana; Apiradee Theamboonlers; Pisit Tangkijvanich; Yong Poovorawan
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

6.  Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.

Authors:  Rujipat Wasitthankasem; Nawarat Posuwan; Preeyaporn Vichaiwattana; Apiradee Theamboonlers; Sirapa Klinfueng; Viboonsak Vuthitanachot; Napha Thanetkongtong; Siriporn Saelao; Monthana Foonoi; Apinya Fakthongyoo; Jamorn Makaroon; Klaita Srisingh; Duangporn Asawarachun; Somchai Owatanapanich; Norra Wutthiratkowit; Kraisorn Tohtubtiang; Pornsak Yoocharoen; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

7.  A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.

Authors:  Anja De Weggheleire; Sokkab An; Irith De Baetselier; Pisith Soeung; Huy Keath; Veasna So; Sreyphors Ros; Syna Teav; Bart Smekens; Jozefien Buyze; Eric Florence; Johan van Griensven; Sopheak Thai; Sven Francque; Lutgarde Lynen
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

8.  Substitution of the CD81 Binding Site and β-Sandwich Area in E2 of HCV in Cambodia.

Authors:  Chikako Yamamoto; Shintaro Nagashima; Channarena Chuon; Ko Ko; Son Huy Do; Oline Lim; Sirany Hok; Somana Svay; Junko Matsuo; Keiko Katayama; Kazuaki Takahashi; Junko Tanaka
Journal:  Viruses       Date:  2020-05-16       Impact factor: 5.048

9.  Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014-2015.

Authors:  François Rouet; Janin Nouhin; Du-Ping Zheng; Benjamin Roche; Allison Black; Sophearot Prak; Marie Leoz; Catherine Gaudy-Graffin; Laurent Ferradini; Chandara Mom; Sovatha Mam; Charlotte Gautier; Gérard Lesage; Sreymom Ken; Kerya Phon; Alexandra Kerleguer; Chunfu Yang; William Killam; Masami Fujita; Chhivun Mean; Didier Fontenille; Francis Barin; Jean-Christophe Plantier; Trevor Bedford; Artur Ramos; Vonthanak Saphonn
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

Review 10.  Viral Hepatitis in Cambodia: Past, Present, and Future.

Authors:  Bun Sreng; Chhith Sophal; Sok Srun; Chham Samnang; Eng Huot
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.